DossierENTITY

Memorial Sloan Kettering

Coverage of Memorial Sloan Kettering in the Nexus archive.

Earliest in view: Apr 18 · 22:51 UTCMost recent: Apr 18 · 22:51 UTC

Co-mentioned in this coverage

Recent coverage

HEALTHApr 18 · 22:51 UTCNBC NEWS
Experimental treatment for pancreatic cancer could be breakthrough for patients
An experimental personalized mRNA vaccine for pancreatic cancer has shown major promise, with the first recipient at Memorial Sloan Kettering now cancer-free for six years. The treatment, highlighted by NBC News' Anne Thompson, could represent a breakthrough for patients.